drugset / Trial / NCT00093301

Levosimendan Versus Dobutamine in Shock Patients

NCT00093301

Phase 2/3 Unknown 40 enrolled Wentworth Area Health Services Abbott · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to compare the efficacy of levosimendan with that of dobutamine in patients with unstable hemodynamics (shock).

Timeline

Start
2004-10
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dobutamine Small molecule
Subject Levosimendan Other / unclassified